| NYHA | New York Heart Association Heart Disease에 대한 Functional Classification &nbs... |
|---|---|
| WDMF | wall-defective microbial forms |
| ABPA | Allergic Broncho-Pulmonary Aspergillosis |
| ABA | abscissic acid; allergic bronchopulmonary aspergillosis; American Board of Anesthesiologists; antiba... |
| ABPA | actin-binding protein, autosomal form; allergic bronchopulmonary aspergillosis |
| ABPA | Allergic Broncho-pulmonary Aspergillosis |
|---|---|
| IPA | Invasive Pulmonary Aspergillosis |
| IA | Invasive aspergillosis |
| DRO | Differential Reinforcement of Other Behaviour |
| MOTT | Mycobacteria Other Than Tuberculosis |
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
|---|---|
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| accole forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| allergic bronchopulmonary aspergillosis | <radiology> ABPA: Aspergillus fumigatus hypersensitivity, mucoid impaction of bronchi distal to lobar bronchus, mucus plugs contain fungi, eosinophils, XR: Y-shaped density (mucus plug wedged in bronchi) (12 Dec 1998) |
| applique forms | A term applied to the manner in which the ring stage of Plasmodium falciparum parasitises the marginal portion of erythrocytes. Synonym: accole forms. (05 Mar 2000) |
| aspergillosis | <disease> A fungal (Aspergillus) infection in the tissues marked by inflammatory granulomatous lesions. This infection may affect the lungs, ear canal, skin or the mucous membranes of the eye, nose or urethra. May cause pulmonary aspergillosis in individuals with asthma. More common in the immunocompromised individual (AIDS). Symptoms of disseminated disease include cough, haemoptysis, weight loss, wheezing, fever, chills, haematuria and decreased urine output. Treatment is with amphotericin B. Not transmissible from human to animals or animals to human. (27 Sep 1997) |
| aspergillosis, allergic bronchopulmonary | Aspergillosis of the lung occurring in an individual with long-standing bronchial asthma. It is characterised by pulmonary infiltrates, eosinophilia, elevated serum IgE and immediate type skin reactivity to aspergillus antigen. (12 Dec 1998) |
| aspergillosis precipitin | <investigation> A test which is used to detect the presence of aspergillus antibodies in the blood. The normal result is read as negative or no antibodies. A strong reaction can indicate pulmonary aspergillosis. Some forms of hypersensitivity pneumonia may also yield a weakly positive test result. (27 Sep 1997) |
| atypical bacterial forms | Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics. (12 Dec 1998) |
| bronchopneumonic aspergillosis | An inflammatory and destructive disease of the bronchi and lungs due to the presence and growth of Aspergillus fumigatus. There are four varieties: 1) a bronchial infection with allergic manifestations, in which the fungus grows in the mucus (evoked by the inflammation), which may be expectorated as yellow bronchial casts and may cause intermittent bronchial obstruction, with transient pulmonary shadows seen radiographically; asthma is often present, and bronchial wall destruction may eventually result in a proximal form of bronchiectasis; 2) aspergilloma; 3) an infection with pulmonary necrosis as a pneumonic involvement of the lung in debilitated subjects; 4) disseminated aspergillosis. Synonym: bronchopneumonic aspergillosis, pulmonary aspergillosis. Disseminated aspergillosis, a variety of bronchopulmonary aspergillosis, characterised by a generalised infection of the lung with Aspergillus occurring usually in subjects with defective immune response. Invasive aspergillosis, so-called because of the peculiar predilection of Aspergillus fumigatus to invade blood vessels and cause tissue infarction; it is second only to candidiasis as a cause of opportunistic fungal infection in patients whose immune mechanisms have been suppressed by chemotherapy. (05 Mar 2000) |
| bronchopulmonary aspergillosis | An inflammatory and destructive disease of the bronchi and lungs due to the presence and growth of Aspergillus fumigatus. There are four varieties: 1) a bronchial infection with allergic manifestations, in which the fungus grows in the mucus (evoked by the inflammation), which may be expectorated as yellow bronchial casts and may cause intermittent bronchial obstruction, with transient pulmonary shadows seen radiographically; asthma is often present, and bronchial wall destruction may eventually result in a proximal form of bronchiectasis; 2) aspergilloma; 3) an infection with pulmonary necrosis as a pneumonic involvement of the lung in debilitated subjects; 4) disseminated aspergillosis. Synonym: bronchopneumonic aspergillosis, pulmonary aspergillosis. Disseminated aspergillosis, a variety of bronchopulmonary aspergillosis, characterised by a generalised infection of the lung with Aspergillus occurring usually in subjects with defective immune response. Invasive aspergillosis, so-called because of the peculiar predilection of Aspergillus fumigatus to invade blood vessels and cause tissue infarction; it is second only to candidiasis as a cause of opportunistic fungal infection in patients whose immune mechanisms have been suppressed by chemotherapy. (05 Mar 2000) |
| pulmonary aspergillosis | An inflammatory and destructive disease of the bronchi and lungs due to the presence and growth of Aspergillus fumigatus. There are four varieties: 1) a bronchial infection with allergic manifestations, in which the fungus grows in the mucus (evoked by the inflammation), which may be expectorated as yellow bronchial casts and may cause intermittent bronchial obstruction, with transient pulmonary shadows seen radiographically; asthma is often present, and bronchial wall destruction may eventually result in a proximal form of bronchiectasis; 2) aspergilloma; 3) an infection with pulmonary necrosis as a pneumonic involvement of the lung in debilitated subjects; 4) disseminated aspergillosis. Synonym: bronchopneumonic aspergillosis, pulmonary aspergillosis. Disseminated aspergillosis, a variety of bronchopulmonary aspergillosis, characterised by a generalised infection of the lung with Aspergillus occurring usually in subjects with defective immune response. Invasive aspergillosis, so-called because of the peculiar predilection of Aspergillus fumigatus to invade blood vessels and cause tissue infarction; it is second only to candidiasis as a cause of opportunistic fungal infection in patients whose immune mechanisms have been suppressed by chemotherapy. (05 Mar 2000) |
| dosage forms | Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include capsules, liniments, ointments, pharmaceutical solutions, powders, tablets, etc. (12 Dec 1998) |
| forms and records control | A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records. (12 Dec 1998) |
| forms of DNA i, II and III | Refers to circular DNA removed from viruses and as plasmids. Form I is the DNA in its normal, supercoiled form. Form II is the DNA after one of the two strands has been nicked (cut apart), and is circular. Form III is the DNA after both strands have been broken, and is linear. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|